Identification and treatment of symptoms associated with inflammation in medically ill patients
Identification and treatment of symptoms associated with inflammation in medically ill patients
Medically ill patients present with a high prevalence of non-specific comorbid symptoms including pain, sleep disorders, fatigue and cognitive and mood alterations that is a leading cause of disability. However, despite major advances in the understanding of the immune-to-brain communication pathways that underlie the pathophysiology of these symptoms in inflammatory conditions, little has been done to translate this newly acquired knowledge to the clinics and to identify appropriate therapies. In a multidisciplinary effort to address this problem, clinicians and basic scientists with expertise in areas of inflammation, psychiatry, neurosciences and psychoneuroimmunology were brought together in a specialized meeting organized in Bordeaux, France, on May 28–29, 2007. These experts considered key questions in the field, in particular those related to identification and quantification of the predominant symptoms associated with inflammation, definition of systemic and central markers of inflammation, possible domains of intervention for controlling inflammation-associated symptoms, and relevance of animal models of inflammation-associated symptoms. This resulted in a number of recommendations that should improve the recognition and management of inflammation-associated symptoms in medically ill patients.
inflammation, depression, fatigue, proinflammatory cytokines, brain, acute phase protein, symptom burden, biologic marker, therapy, animal models, neuroimaging
18-29
Dantzer, Robert.
66b7af6c-74b8-4380-aed2-7c91bf271f81
Capuron, Lucile
62354af2-7fe3-46a3-b996-ac03502dad65
Irwin, Michael.R.
b90c2be9-c1cd-4631-9f58-351ea1482c19
Millers, Andrew.H.
cbab9ba3-e98d-4092-81c3-c8546aa18a8e
Ollat, Helene
e387999a-ef3d-4241-b1bd-57acb99d2806
Perry, Victor Hugh
8f29d36a-8e1f-4082-8700-09483bbaeae4
Rousey, Sarah
aee9e20a-6c14-40fe-8462-0c53191a6742
Yirmiyag, Raz
1fa23b73-3a5c-4aa5-9731-8c3da39287dc
1 January 2008
Dantzer, Robert.
66b7af6c-74b8-4380-aed2-7c91bf271f81
Capuron, Lucile
62354af2-7fe3-46a3-b996-ac03502dad65
Irwin, Michael.R.
b90c2be9-c1cd-4631-9f58-351ea1482c19
Millers, Andrew.H.
cbab9ba3-e98d-4092-81c3-c8546aa18a8e
Ollat, Helene
e387999a-ef3d-4241-b1bd-57acb99d2806
Perry, Victor Hugh
8f29d36a-8e1f-4082-8700-09483bbaeae4
Rousey, Sarah
aee9e20a-6c14-40fe-8462-0c53191a6742
Yirmiyag, Raz
1fa23b73-3a5c-4aa5-9731-8c3da39287dc
Dantzer, Robert., Capuron, Lucile, Irwin, Michael.R., Millers, Andrew.H., Ollat, Helene, Perry, Victor Hugh, Rousey, Sarah and Yirmiyag, Raz
(2008)
Identification and treatment of symptoms associated with inflammation in medically ill patients.
Psychoneuroendocrinology, 33 (1), .
(doi:10.1016/j.psyneuen.2007.10.008).
Abstract
Medically ill patients present with a high prevalence of non-specific comorbid symptoms including pain, sleep disorders, fatigue and cognitive and mood alterations that is a leading cause of disability. However, despite major advances in the understanding of the immune-to-brain communication pathways that underlie the pathophysiology of these symptoms in inflammatory conditions, little has been done to translate this newly acquired knowledge to the clinics and to identify appropriate therapies. In a multidisciplinary effort to address this problem, clinicians and basic scientists with expertise in areas of inflammation, psychiatry, neurosciences and psychoneuroimmunology were brought together in a specialized meeting organized in Bordeaux, France, on May 28–29, 2007. These experts considered key questions in the field, in particular those related to identification and quantification of the predominant symptoms associated with inflammation, definition of systemic and central markers of inflammation, possible domains of intervention for controlling inflammation-associated symptoms, and relevance of animal models of inflammation-associated symptoms. This resulted in a number of recommendations that should improve the recognition and management of inflammation-associated symptoms in medically ill patients.
This record has no associated files available for download.
More information
Published date: 1 January 2008
Keywords:
inflammation, depression, fatigue, proinflammatory cytokines, brain, acute phase protein, symptom burden, biologic marker, therapy, animal models, neuroimaging
Identifiers
Local EPrints ID: 55968
URI: http://eprints.soton.ac.uk/id/eprint/55968
ISSN: 0306-4530
PURE UUID: 9d6383ed-aaf8-421b-9104-6e336528a966
Catalogue record
Date deposited: 11 Aug 2008
Last modified: 15 Mar 2024 10:58
Export record
Altmetrics
Contributors
Author:
Robert. Dantzer
Author:
Lucile Capuron
Author:
Michael.R. Irwin
Author:
Andrew.H. Millers
Author:
Helene Ollat
Author:
Sarah Rousey
Author:
Raz Yirmiyag
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics